The seventh webinar in the “Let’s Talk MPTs” Discussion Series featured end-user researchers, product developers, and marketing experts with extensive experience in MPT R&D. The presentations centered discussion around challenges and strategies for conducting end-user research in the early stages of product development, as well as utilizing the findings to effectively inform product development and commercialization strategies. Following the webinar, our esteemed panelists were given the opportunity to elaborate on the thoughtful questions posed by audience members.
Most people would say they’re familiar with the concept of self-care. Dominating the self-care space are multi-step skincare routines, bubble baths, gratitude journals, smoothies, cleanses and countless other low-cost, self-pampering activities usually offering immediate physical and emotional benefits. Colloquially, self-care has come to typify a handful of popularized behaviors and trends, but it also holds a much larger potential to empower autonomy over our well-being at both an individual and preventative level.
Hello! My name is Hannah Rubens, and I am thrilled to have the opportunity to support CAMI Health as a Public Health Intern this summer. I have recently completed my Bachelor’s degree in Public Health Science, and, over the course of my experience at Santa Clara University, have grown most excited about the potential of the public health field to mitigate health inequities through a systems-level approach.
I figured out relatively early on that the female experience was deeply interesting to me. Attending an all-girls high school likely played a large role in this realization, as here women were clearly the focus of everything from the novels we read to the sports teams and even in theater where girls often took on the traditionally male roles in the shows. Throughout the four years I spent at my high school, I gained an unrivaled sense of pride in my identity as a woman that has and continues to shape my experiences heavily.
There are many complexities in developing MPTs that will be safe, effective, affordable, and used by women. One key aspect of this process is to study the desirability and acceptability of an MPT candidate during its development.
We join the world in celebrating International Women’s Day by calling out all MPT champions who work to provide women everywhere with more product choices designed to simultaneously prevent HIV, STIs, and/or pregnancy so women can manage their reproductive health and futures. We choose to challenge barriers to safe, effective, and affordable reproductive health access […]
This past year has been an exceptionally challenging one, with the devastating coronavirus pandemic (COVID-19) and other global crises affecting populations around the world. While recognizing the tremendous loss and setbacks that these crises have caused, here at the Initiative for Multipurpose Prevention Technologies (IMPT) we have also been deeply inspired by humanity’s resilience, solidarity, […]
The IMPT recently released its updated MPT Product Development Database. The IMPT Secretariat conducted the annual update process between February and June of 2020 and launched the updated database in July 2020. Resources used to update the database included: product developer updates, published peer-reviewed literature, relevant scientific conferences, and publicly available funding data. The following […]
The IMPT offices are always a buzz with activity during the months of November and December. Giving Tuesday, World AIDS Day, as well as general end-of-the year wrap ups—it is a reminder that for organizations like ours, this time of year is a time for increased activism, awareness, and reflection. This year, as the IMPT […]
In 1960, FDA approval of the first hormonal contraceptive—more commonly known as “the pill”—revolutionized sexual and reproductive health, giving women unprecedented control over their fertility for the first time in history. Today, there are a range of contraceptive products available to women across the globe. Of the over 30 MPTs in the product development pipeline, […]